Johnson & Johnson is a general drug manufacturer company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker JNJ on the NYSE exchange.
Johnson & Johnson stock last closed at $161.46, up 0.59% from the previous day, and has increased 3.38% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.15 percentage points. Johnson & Johnson stock is currently +12.81% from its 52-week low of $143.13, and -4.38% from its 52-week high of $168.85.
As of Oct 11, 2024, there are 2.41B shares of JNJ outstanding. The market capitalization of JNJ is $388.67B. In the last 24 hours, 5.18M JNJ shares were traded.
You need a brokerage account in order to access the NYSE market and buy JNJ stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountNow that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in JNJ stock today.
Now that you've filled out your info on one of the best stock trading apps, you can securely and quickly fund your account:
Watch the video below if you need help transferring money into your brokerage account.
After you have identified the best place to buy Johnson & Johnson stock, it's crucial to evaluate their stock before you buy, so you truly comprehend the risk as well as the upside.
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on JNJ's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge JNJ's fair value.
Using relative valuations measures:
You can access more valuation research on JNJ's stock here.
Out of 8 Equities analysts who research JNJ, the consensus analyst rating on JNJ is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Terence Flynn, a top 7% analyst from Morgan Stanley maintains JNJ with a hold rating and raises their JNJ price target from $167.00 to $169.00, on Jul 18, 2024.
Morten Herholdt, a bottom 18% analyst from HSBC upgrades JNJ to a strong buy rating and raises their JNJ price target from $169.00 to $170.00, on Apr 18, 2024.
HSBC's Morten Herholdt upgraded their rating on Johnson & Johnson (NYSE: JNJ) from Hold to Strong Buy on 2024/04/18. The analyst also raised their price target by 0.6% from $169 to $170.
Johnson & Johnson stock has discounted to a three-year low in spite of "unchanged fundamentals and well-known headwinds," the analyst pointed out.
At its current valuation, the stock has "asymmetric risk, attractive upside, and diversity that limits material operational downside," Herholdt argued, adding that a resolution of the Talc lawsuit would be positive for the share price.
Geoff Meacham, a bottom 5% analyst from Bank of America maintains JNJ with a hold rating and lowers their JNJ price target from $180.00 to $170.00, on Apr 17, 2024.
You can dig deeper into what analysts are forecasting on the Johnson & Johnson stock forecast page.
Last year, JNJ earnings were $38.02B. During the past 5 year, JNJ's earnings have grown by 20% per year. This was faster than the Drug Manufacturers - General industry average of 3.53%.
Last year, JNJ revenue was $78.71B. Over the past 5 year, JNJ's revenue has gone up by -0.65% per year. This was slower than the Drug Manufacturers - General industry average of 7.9%.
You can analyze JNJ's earnings and revenue performance here.
In the past year, executives and large shareholders at JNJ have sold more shares than they have bought.
Robert J. Decker, VP Corporate Controller of JNJ, was the latest JNJ insider to sell. They sold $930,113.10 worth of JNJ stock on Aug 30, 2024.
Learn more about who owns JNJ shares here.
Johnson & Johnson pays a dividend of 3.01%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.18%. If you owned $1,000 of JNJ stock, you would have been paid $30.10 in the past year.
Johnson & Johnson dividend payments have consistently grown over the past decade and have remained stable.
Get more info about Johnson & Johnson dividend yield and history here.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main options:
Press the Open Trade button and your broker will execute the order.
If you want additional assistance investing in stocks on eToro, click the helpful video below:
Now that you own some JNJ stock, you'll want to keep up with your new shares.
Start a watchlist to keep track of your JNJ stock.
To reiterate, here are the 6 steps to buy stock in Johnson & Johnson:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Johnson & Johnson, add JNJ to your watchlist below.